Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, et al. Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL. Ann Oncol 2020 Dec 29. pii: S0923-7534(20)43221.
PMID: 33385521